1.
Cong L. CRISPR: Groundbreaking technology for RNA-guided genome engineering. Anal Biochem. 2017;532:87-89. doi:10.1016/j.ab.2017.05.005.
1.
Kwong LN, Zou L, Chagani S, et al. Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma. Cell Rep. 2017;19(7):1304-1312. doi:10.1016/j.celrep.2017.04.065.
1.
Gao L, Cox DBT, Yan WX, et al. Engineered Cpf1 variants with altered PAM specificities. Nat Biotechnol. 2017;35(8):789-792. doi:10.1038/nbt.3900.
1.
Johns NI, Gomes ALC, Yim SS, et al. Metagenomic mining of regulatory elements enables programmable species-selective gene expression. Nat Methods. 2018;15(5):323-329. doi:10.1038/nmeth.4633.
1.
Certain LK, Way JC, Pezone MJ, Collins JJ. Using Engineered Bacteria to Characterize Infection Dynamics and Antibiotic Effects In Vivo. Cell Host Microbe. 2017;22(3):263-268.e4. doi:10.1016/j.chom.2017.08.001.
1.
Casini A, Chang F-Y, Eluere R, et al. A Pressure Test to Make 10 Molecules in 90 Days: External Evaluation of Methods to Engineer Biology. J Am Chem Soc. 2018;140(12):4302-4316. doi:10.1021/jacs.7b13292.
1.
Shapiro RS, Chavez A, Collins JJ. CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms. Nat Rev Microbiol. 2018;16(6):333-339. doi:10.1038/s41579-018-0002-7.
1.
Lee JW, T Y Chan C, Slomovic S, Collins JJ. Next-generation biocontainment systems for engineered organisms. Nat Chem Biol. 2018;14(6):530-537. doi:10.1038/s41589-018-0056-x.
1.
Huang J, Schreiber SL. A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proc Natl Acad Sci U S A. 1997;94(25):13396-401.
1.
Bouziat R, Hinterleitner R, Brown JJ, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356(6333):44-50. doi:10.1126/science.aah5298.